According to the latest report by IMARC Group, titled “Structural Heart Imaging Market Report by Imaging Modality (Echocardiogram, Angiogram), Procedure Type (Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Transcatheter Mitral Valve Repair (TMVR), Left Atrial Appendage Closure (LAAC), Annuloplasty, Valvuloplasty, and Others), Application (Diagnosis, Surgery), End User (Hospitals, Specialty Clinics, Cardiac Centers, Diagnostic Centers, Ambulatory Surgical Centers, Catheterization Laboratories, and Others), and Region 2025-2033," the global structural heart imaging market reached a value of USD 21.5 Billion in 2024. Structural heart imaging (SHI) refers to a special technique employed to screen and examine the heart at the molecular level. It utilizes high-resolution cameras and magnetic resonance imaging (MRI) with high tesla capacity to carry out structural heart imaging. SHI includes the utilization of light reflection to produce the image of the interior component and create a 2-dimensional (2D) cross-section interpretation to achieve an accurate diagnosis. Apart from this, it assists medical professionals in performing various operative procedures, such as locating the pathways and blockages for insertion by minimizing the risk of interference.
Global Structural Heart Imaging Market Trends:
One of the key factors driving the SHI market growth is the growing instances of congenital heart diseases (CHDs) and lifestyle-induced ailments, such as obesity, diabetes, and high blood pressure. SHI is widely used for diagnosing cardiovascular conditions with the help of high precision and resolution cameras and sensors. In line with this, the rising health consciousness and awareness among patients about the availability of cardiac care is favoring the market growth. Apart from this, various product innovations, such as the introduction of transcatheter aortic valve replacement (TAVR) for performing angioplasty and ensuring faster patient recovery post-surgery, are providing a considerable boost to the market growth. Additionally, significant technological advancements in imaging techniques and increasing clinical trials are acting as other growth-inducing factors. Besides this, extensive research and development (R&D) activities and the implementation of various government initiatives focusing on improving the healthcare infrastructure are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach USD 47.6 Billion by 2033, exhibiting a CAGR of 8.74% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Imaging Modality, Procedure Type, Application, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation, Integer Holdings Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V. and Siemens Healthcare GmbH |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800